Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Pediatrics
Volume 2016, Article ID 2659389, 3 pages
http://dx.doi.org/10.1155/2016/2659389
Case Report

Ibuprofen for Ductus Arteriosus Months after Birth

1Division of Neonatology, Department of Pediatrics, Erasmus MC-Sophia Children’s Hospital, Wytemaweg 80, 3015 CN Rotterdam, Netherlands
2Division of Pediatric Cardiology, Department of Pediatrics, Erasmus MC-Sophia Children’s Hospital, Wytemaweg 80, 3015 CN Rotterdam, Netherlands

Received 19 January 2016; Revised 21 April 2016; Accepted 23 May 2016

Academic Editor: Jonathan Muraskas

Copyright © 2016 Odile Frauenfelder et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. J. Jones, P. D. Craven, J. Attia, A. Thakkinstian, and I. Wright, “Network meta-analysis of indomethacin versus ibuprofen versus placebo for PDA in preterm infants,” Archives of Disease in Childhood: Fetal and Neonatal Edition, vol. 96, no. 1, pp. F45–F52, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Ohlsson and S. S. Shah, “Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants,” Cochrane Database of Systematic Reviews, no. 7, Article ID CD004213, 2011. View at Google Scholar · View at Scopus
  3. D. Hirt, B. Van Overmeire, J.-M. Treluyer et al., “An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study,” British Journal of Clinical Pharmacology, vol. 65, no. 5, pp. 629–636, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Dani, G. Bertini, I. Corsini et al., “The fate of ductus arteriosus in infants at 23–27 weeks of gestation: from spontaneous closure to ibuprofen resistance,” Acta Paediatrica, vol. 97, no. 9, pp. 1176–1180, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Bökenkamp, M. C. DeRuiter, C. van Munsteren, and A. C. Gittenberger-de Groot, “Insights into the pathogenesis and genetic background of patency of the ductus arteriosus,” Neonatology, vol. 98, no. 1, pp. 6–17, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Ohlsson, R. Walia, and S. S. Shah, “Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants,” The Cochrane Database of Systematic Reviews, vol. 2, Article ID CD003481, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Gudmundsdottir, S. Johansson, S. Håkansson, M. Norman, K. Källen, and A.-K. Bonamy, “Timing of pharmacological treatment for patent ductus arteriosus and risk of secondary surgery, death or bronchopulmonary dysplasia: a population-based cohort study of extremely preterm infants,” Neonatology, vol. 107, no. 2, pp. 87–92, 2015. View at Publisher · View at Google Scholar · View at Scopus